H1B Report
Side-by-side comparison

INFOSYS LIMITED vs Roche Molecular Systems, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235
Entity B
Roche Molecular Systems, Inc.
CARank #FEIN 22-3140457

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDRoche Molecular Systems, Inc.
Total filings200,329265
Certified %99.55%74.72%
Denied %0.21%0.00%
Withdrawn %0.20%1.51%
Cert-withdrawn %0.05%23.77%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXCA

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — Roche Molecular Systems, Inc.

DOL case-status mix.

Outcome breakdown: Certified 74.7%, Cert-withdrawn 23.8%, Withdrawn 1.5%
Outcome breakdown
OutcomeShare
Certified74.7%
Cert-withdrawn23.8%
Withdrawn1.5%
Certified74.7%
Cert-withdrawn23.8%
Withdrawn1.5%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,138
FY20111,681
FY201214,633
FY201331,994
FY201423,467
FY201532,976
FY201624,049
FY201720,254
FY201811,519
FY201921,102
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20262,447
Roche Molecular Systems, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20114
FY20124
FY20138
FY20143
FY201515
FY201625
FY201725
FY201844
FY201953
FY20200
FY20210
FY20220
FY202313
FY202432
FY202529
FY20266

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — Roche Molecular Systems, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.